Navigation Links
International Merchant Advisors, Inc. Signs LOI to Invest in Pharmaceutical Chain
Date:2/16/2010

KINGWOOD, Texas, Feb. 16 /PRNewswire-FirstCall/ -- International Merchant Advisors, Inc. (Pink Sheets: IMAI.PK) www.imaiinc.com announced today that the company has signed a letter of intent  to purchase a minority interest in Assured Pharmacy, Inc. (Pink Sheets: APHY.PK) www.assuredpharmacyinc.com, a retail pharmaceutical operation that is focused on selling prescription medications in the chronic pain management medical sector. Assured Pharmacy has gross revenues in eight figures, and has experienced management and staff to accelerate the IMAI plan to open Wellness Centers in selected spots throughout the USA.  Corporate Strategies' CEO Tim Connolly is advising the companies on the transaction and is developing the structure of the proposed joint venture.

IMAI CEO Mel Roseman said, "Assuming both parties elect to move forward on our LOI, we will enter the healthcare services sector in a jointly owned project for opening Wellness Centers with Assured Pharmacy, with IMAI retaining 51% of the equity and operating control of the venture, and Assured owning 49% and bringing their expertise in the traditional chronic pain treatment modality. IMAI will bring the required capital and alternative, natural treatment medical and legal professionals to the venture. Medicare/Medicaid and healthcare reform from both the Obama Administration and Congress will continue to pressure traditional medical clinics, and we intend to bring not only lower cost, natural treatment methodology to communities with our MD supervised Wellness Centers, but we will introduce medical marijuana as a natural pain reliever in our Wellness Centers located in those states that allow its legal operation."

Assured Pharmacy CEO Robert Del Vecchio added, "The concept of Wellness Centers offering lower cost alternatives for both traditional therapeutic courses of treatment as well as natural, effective pain treatment products such as medical marijuana is intriguing to us, and we look forward to carefully researching the medical, legal, and practical issues related to opening these new Wellness Centers, and hope to complete our due diligence to pursue this venture with IMAI as quickly as possible."

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.

SOURCE International Merchant Advisors, Inc.

RELATED LINKS
http://www.imaiinc.com

'/>"/>

SOURCE International Merchant Advisors, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... Calif. , Dec. 5, 2016 Sanovas, ... technology accelerator, announced today the launch of its wholly owned ... Logo - http://photos.prnewswire.com/prnh/20161202/445250LOGO   Logo - http://photos.prnewswire.com/prnh/20161202/445251LOGO ... ... There ...
(Date:12/5/2016)... Dec. 5, 2016  Wellbridge Health and Gateway Health proudly ... solutions to Medicare and Medicaid plan members with specific high ... the unique needs of this group of consumers, Wellbridge combines ... philosophies to provide insight into members, daily behaviors and lifestyle. ... , , ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... BSI and Brenntag Canada ... States and Canada for distribution of their natural fruits and beverage colorants ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, President ...
(Date:12/5/2016)... ... 2016 , ... Sideline Products is a Southern York County Pennsylvania-based premier designer ... and the horse. Smaller saddles can pinch and irritate the horse creating safety issues ... properly fitted western saddle so it does not impact the comfort or performance of ...
(Date:12/5/2016)... , ... December 05, 2016 , ... “Life Will Never ... a supportive family and friends. “Life Will Never Be The Same” is the creation ... course in writing children's books and holds a degree in Christian religion and philosophy ...
(Date:12/5/2016)... ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the Retina Group of ... York was founded by James M. Maisel, MD and has been providing tertiary medical and ... followed a legacy of surpassing expectations amongst her peers. Growing up in a family ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... ensure moisture measurements are consistently correct. However, regular performance testing is often ... TOLEDO offers a solution: SmartCal™ . This innovative test substance offers ...
Breaking Medicine News(10 mins):